Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab in Pakistani Patients With Rheumatoid Arthritis
NCT02731560Phase 4Completed
- Start
- Jan 2010
- Primary completion
- Jul 2011
- Modality
- Monoclonal Antibodies
01
Overview
Phase 4, open-label, single-arm trial of rituximab in rheumatoid arthritis (RA). Primary endpoint: Disease Activity Score-28 at 6 months. Started Jan 2010; status: completed.
02
Drugs
rituximab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT02731560.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02731560.